The corrected WS SC‐β cells had increased insulin secretion, could be robustly differentiated, and transplanted into mice with reversed streptozotocin‐induced diabetes, suggesting that correction of patient‐derived iPSCs using CRISPR/Cas9 may provide cells with therapeutic utility in diabetic cell replacement therapy.372. Here, INS is linked to diabetes mellitus.